Sight Sciences (SGHT) News Today $2.53 -0.23 (-8.33%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$2.53 0.00 (-0.04%) As of 02/21/2025 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Brokerages Set Sight Sciences, Inc. (NASDAQ:SGHT) Price Target at $4.68February 22 at 1:11 AM | americanbankingnews.comSight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025February 19 at 4:05 PM | globenewswire.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Rating of "Hold" from AnalystsSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been given a consensus rating of "Hold" by the seven research firms that are currently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and two have issued a buy recommenFebruary 19 at 2:20 AM | marketbeat.comSight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access DayFebruary 13, 2025 | finance.yahoo.comSight Sciences to Present at Citi's 2025 Unplugged MedTech and Life Sciences Access DayFebruary 13, 2025 | globenewswire.comSight Sciences stock hits 52-week low at $2.54 amid market challengesFebruary 13, 2025 | msn.comStifel Nicolaus Has Lowered Expectations for Sight Sciences (NASDAQ:SGHT) Stock PriceStifel Nicolaus dropped their target price on shares of Sight Sciences from $6.00 to $5.00 and set a "buy" rating on the stock in a research note on Thursday.February 6, 2025 | marketbeat.comSight Sciences executives receive salary increases and bonus targetsJanuary 29, 2025 | msn.comUBS Group Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $5.00UBS Group lowered their price objective on shares of Sight Sciences from $5.50 to $5.00 and set a "buy" rating for the company in a research report on Monday.January 27, 2025 | marketbeat.comSight Sciences price target lowered to $5 from $5.50 at UBSJanuary 26, 2025 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) Given Average Recommendation of "Hold" by BrokeragesShares of Sight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) have received a consensus rating of "Hold" from the six brokerages that are presently covering the company, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and one has assigned a buy recoJanuary 25, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $15,075.94 in StockJanuary 23, 2025 | insidertrades.comSight sciences CTO David Badawi sells $15,081 in stockJanuary 22, 2025 | msn.comSight Sciences, Inc. (NASDAQ:SGHT) CTO David Badawi Sells 5,423 SharesSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 5,423 shares of the firm's stock in a transaction on Friday, January 17th. The stock was sold at an average price of $2.78, for a total transaction of $15,075.94. Following the transaction, the chief technology officer now directly owns 1,744,118 shares in the company, valued at $4,848,648.04. The trade was a 0.31 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.January 22, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Jeremy B. Hayden Sells 6,922 SharesJanuary 22, 2025 | insidertrades.comSight sciences chief legal officer sells shares worth $19,250January 22, 2025 | msn.comSight sciences CEO Paul Badawi sells shares worth $72,570January 22, 2025 | msn.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells 6,922 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Jeremy B. Hayden sold 6,922 shares of the business's stock in a transaction that occurred on Friday, January 17th. The shares were sold at an average price of $2.78, for a total value of $19,243.16. Following the completion of the sale, the insider now owns 145,091 shares of the company's stock, valued at approximately $403,352.98. This trade represents a 4.55 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.January 21, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CEO Sells $72,471.48 in StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CEO Paul Badawi sold 24,819 shares of the company's stock in a transaction dated Thursday, January 16th. The shares were sold at an average price of $2.92, for a total transaction of $72,471.48. Following the sale, the chief executive officer now directly owns 5,676,331 shares of the company's stock, valued at $16,574,886.52. The trade was a 0.44 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.January 21, 2025 | marketbeat.comKck Ltd. Invests $15.93 Million in Sight Sciences, Inc. (NASDAQ:SGHT)Kck Ltd. acquired a new stake in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 4,374,975 shares of the company's stock, valued at approximately $15,925January 19, 2025 | marketbeat.comCiti Remains a Hold on Sight Sciences (SGHT)January 17, 2025 | markets.businessinsider.comSight Sciences price target lowered to $3 from $5 at Lake StreetJanuary 16, 2025 | markets.businessinsider.comExpert Outlook: Sight Sciences Through The Eyes Of 5 AnalystsJanuary 15, 2025 | benzinga.comLake Street Capital Cuts Sight Sciences (NASDAQ:SGHT) Price Target to $3.00Lake Street Capital decreased their target price on Sight Sciences from $5.00 to $3.00 and set a "hold" rating for the company in a research note on Wednesday.January 15, 2025 | marketbeat.comSight Sciences (SGHT) Receives a Hold from NeedhamJanuary 15, 2025 | markets.businessinsider.comStifel Nicolaus Sticks to Their Buy Rating for Sight Sciences (SGHT)January 15, 2025 | markets.businessinsider.comSight Sciences (NASDAQ:SGHT) Earns "Hold" Rating from Needham & Company LLCNeedham & Company LLC reaffirmed a "hold" rating on shares of Sight Sciences in a report on Tuesday.January 14, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) CTO Sells $12,482.54 in StockJanuary 11, 2025 | insidertrades.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,829 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 3,829 shares of Sight Sciences stock in a transaction on Wednesday, January 8th. The stock was sold at an average price of $3.26, for a total transaction of $12,482.54. Following the sale, the chief technology officer now owns 1,749,541 shares in the company, valued at $5,703,503.66. This represents a 0.22 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.January 10, 2025 | marketbeat.comSight Sciences study demonstrates benefits of OMNI system for managing POAGJanuary 8, 2025 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) CTO David Badawi Sells 3,111 SharesJanuary 7, 2025 | insidertrades.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CTO Sells 3,111 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CTO David Badawi sold 3,111 shares of the stock in a transaction dated Friday, January 3rd. The stock was sold at an average price of $3.52, for a total transaction of $10,950.72. Following the sale, the chief technology officer now owns 1,753,370 shares of the company's stock, valued at $6,171,862.40. This trade represents a 0.18 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.January 6, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $17,121.28 in StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) insider Jeremy B. Hayden sold 4,864 shares of Sight Sciences stock in a transaction on Friday, January 3rd. The shares were sold at an average price of $3.52, for a total transaction of $17,121.28. Following the completion of the sale, the insider now owns 153,823 shares in the company, valued at approximately $541,456.96. This represents a 3.07 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website.January 6, 2025 | marketbeat.comInsider Selling: Sight Sciences, Inc. (NASDAQ:SGHT) CEO Sells 12,236 Shares of StockSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) CEO Paul Badawi sold 12,236 shares of the company's stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $3.60, for a total value of $44,049.60. Following the sale, the chief executive officer now directly owns 5,713,197 shares in the company, valued at $20,567,509.20. This trade represents a 0.21 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.January 6, 2025 | marketbeat.comSight Sciences, Inc. (NASDAQ:SGHT) Given Average Rating of "Hold" by BrokeragesSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been given an average rating of "Hold" by the six research firms that are presently covering the stock, Marketbeat.com reports. Five investment analysts have rated the stock with a hold recommendation and one has issued a buy recommendationDecember 31, 2024 | marketbeat.comLake Street Issues a Hold Rating on Sight Sciences (SGHT)December 22, 2024 | markets.businessinsider.comSight Sciences does BIA of TearCare to treat MGD-associated DED in USDecember 21, 2024 | markets.businessinsider.comSight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment OptionsDecember 19, 2024 | globenewswire.comSight Sciences price target lowered to $4.60 from $5.80 at CitiDecember 11, 2024 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) EVP Buys $19,250.00 in StockDecember 10, 2024 | insidertrades.comUBS Initiates Coverage of Sight Sciences (SGHT) with Buy RecommendationDecember 7, 2024 | msn.comPromising Growth Prospects for Sight Sciences Driven by TearCare and OMNI SolutionsDecember 6, 2024 | markets.businessinsider.comSight Sciences, Inc. (NASDAQ:SGHT) Receives Consensus Recommendation of "Hold" from AnalystsSight Sciences, Inc. (NASDAQ:SGHT - Get Free Report) has been given a consensus recommendation of "Hold" by the six research firms that are covering the stock, Marketbeat reports. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. TheDecember 6, 2024 | marketbeat.comManohar K. Raheja Buys 3,376 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockDecember 6, 2024 | insidertrades.comSight Sciences (NASDAQ:SGHT) Coverage Initiated at UBS GroupUBS Group began coverage on shares of Sight Sciences in a report on Friday. They set a "buy" rating and a $5.50 price objective for the company.December 6, 2024 | marketbeat.comManohar K. Raheja Purchases 4,624 Shares of Sight Sciences, Inc. (NASDAQ:SGHT) StockDecember 4, 2024 | insidertrades.comSight Sciences assumed with an Equal Weight at Morgan StanleyDecember 3, 2024 | markets.businessinsider.comMillrace Asset Group Inc. Acquires New Shares in Sight Sciences, Inc. (NASDAQ:SGHT)Millrace Asset Group Inc. bought a new stake in shares of Sight Sciences, Inc. (NASDAQ:SGHT - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 138,793 shares of the company's stock, valuedNovember 26, 2024 | marketbeat.comSight sciences EVP Manohar Raheja acquires $7,400 in stockNovember 23, 2024 | uk.investing.comSight Sciences director Encrantz sells $2.06 million in stockNovember 23, 2024 | investing.com Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address SGHT Media Mentions By Week SGHT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SGHT News Sentiment▼0.510.60▲Average Medical News Sentiment SGHT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SGHT Articles This Week▼22▲SGHT Articles Average Week Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DCTH News CLPT News SMLR News TCMD News NNOX News NPCE News CVRX News ZIMV News NYXH News SMTI News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SGHT) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGHT Stock Alerts